RedHill Biopharma Adds Israel Rights to Movantik® From AstraZeneca
08 oct. 2020 10h30 HE
|
RedHill Biopharma Ltd.
RedHill obtains Israel rights to Movantik® from AstraZeneca, giving RedHill global rights, excluding Europe and Canada--Movantik approved for opioid-induced constipation in Israel under the brand name...
RedHill Biopharma Announces New Agreement with Daiichi Sankyo for Movantik®
03 août 2020 07h00 HE
|
RedHill Biopharma Ltd.
RedHill acquired Movantik® for opioid induced constipation from AstraZeneca in April 2020; Movantik® generated $96 million in 2019 --RedHill and Daiichi Sankyo replaced their co-commercialization...